Increasing contamination of surroundings by emission of toxins has elevated the risks of ocular inflammation, conjointly referred to as uveitis. Evolving medical technologies and drug discovery developments have paved approach for effective treatment of ocular inflammation. a variety of options for treatment of ocular inflammation are being offered to patients – mild inflammations are being treated by the use of corticosteroid eye drops, whereas oral administration of immunosuppressive agents is being most well-liked to treat posterior uveitis in both eyes.
How Big is The Global Ocular Inflammation Treatment Market?
The Ocular Inflammation Treatment Market is expected to be around US$ 630 Billion by 2028 at a CAGR of 6% in the given forecast period.
The Ocular Inflammation Treatment Market has been segmented as below:
By Disease Type:
By Treatment Type:
By Mode of Operation:
By Distribution Channel:
By Regional Analysis:
The Ocular Inflammation Treatment Market is segmented on the lines of its treatment type, disease type, mode of operation, distribution channel and regional. Based on treatment type it covers Corticosteroids, Antibiotics, Monoclonal Antibodies, Immunosuppressant, Cycloplegic, Antivirals, Antifungal and Analgesics. Based on disease type it covers Anterior Uveitis, Posterior Uveitis, Panuveitis, Intermediate Uveitis and Episcleritis/Scleritis. Based on mode of operation it covers Topical, Injectables, Oral and Others. Based on distribution channel it covers Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores. The Ocular Inflammation Treatment Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Ocular Inflammation Treatment Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Ocular Inflammation Treatment Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Ocular Inflammation Treatment Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Allergan Plc, Valeant Pharmaceuticals International, Inc, Novartis AG, Abbvie, Inc, Pfizer, Inc, Cipla Ltd, Akorn, Inc, Eyegate Pharmaceuticals, Inc, Alimera Sciences, Inc and pSivida Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Ocular Inflammation Treatment Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Ocular Inflammation Treatment Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Overactive Bladder Treatment Market
Parkinson’s Disease Treatment Market
Veterinary Surgical Instruments Market
1. Introduction
1.1 Key Findings
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Summary with Insights
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restraints
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Ocular Inflammation Treatment Market Analysis, By Treatment Type
5.1 Corticosteroids
5.2 Antibiotics
5.3 Monoclonal Antibodies
5.4 Immunosuppressant
5.5 Cycloplegic
5.6 Antivirals
5.7 Antifungal
5.8 Analgesics
6. Ocular Inflammation Treatment Market Analysis, By Disease Type
6.1 Anterior Uveitis
6.2 Posterior Uveitis
6.3 Panuveitis
6.4 Intermediate Uveitis
6.5 Episcleritis/Scleritis
7. Ocular Inflammation Treatment Market Analysis, By Mode of Administration
7.1 Topical
7.2 Injectables
7.3 Oral
7.4 Others
8. Ocular Inflammation Treatment Market Analysis, By Distribution Channel
8.1 Hospital Pharmacies
8.2 Retail Pharmacies
8.3 Online Pharmacies
8.4 Drug Stores
9. Ocular Inflammation Treatment Market Analysis, By Region
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
10. Competitive Overview
10.1 Introduction
10.2 New Product Launches
10.3 Acquisitions
10.4 Agreements, Partnerships, And Collaborations
10.5 Expansions
11. Company Profiles
11.1 Pfizer, Inc.
11.2 Cipla Ltd.
11.3 Abbvie, Inc.
11.4 Alimera Sciences, Inc.
11.5 pSivida Corporation
11.6 Akorn, Inc.
11.7 Allergan Plc
11.8 Valeant Pharmaceuticals International, Inc.
11.9 Novartis AG
11.10 Eyegate Pharmaceuticals, Inc.
The Ocular Inflammation Treatment Market has been segmented as below:
By Disease Type:
By Treatment Type:
By Mode of Operation:
By Distribution Channel:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
